White House officials discussed drug-pricing policy ideas proposed by House Speaker Nancy Pelosi’s (D-CA) office in a meeting with Republican lawmakers last week, Freedom Caucus Chair Mark Meadows (R-NC) said Tuesday (June 11). Meadows told Inside Health Policy he did not see how his objections to Pelosi’s latest arbitration plan could be resolved. Energy & Commerce health subcommittee ranking Republican Michael Burgess (TX) was also at the meeting. Burgess’ panel shares jurisdiction over drug-pricing policy, and he said he...